Merck Pfizer Alliance - New developments in mUC and mRCC: The year 2020 in review (ID 41)

Time
12:00 - 13:30

Introduction (ID 1249)

Milestones in 2020: key data from first-line mUC trials (ID 1250)

From data to clinical practice: today’s data in tomorrow’s management of mUC (ID 1251)

Individualizing systemic therapy in mRCC (ID 1252)